Creative Planning
CTSO icon

Creative Planning’s Cytosorbents Corp CTSO Stock Holding History

Creative Planning’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-820
Closed -$1K – 1979
2018
Q3 		$1K Sell
820
-180
-18% -$45.1K ﹤0.01% 2051
2018
Q2 		$12K Buy
+1,000
New +$189K ﹤0.01% 1941

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Creative Planning's CTSO Position: Q2 2026 in Review

Creative Planning reduced its Cytosorbents Corp (CTSO) stake by 11% in Q2 2026, selling an estimated $1.24K and leaving 948 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4238.

Creative Planning first reported a position in CTSO in Q4 2015 and has held it in 40 quarters since. The position peaked at $617K in Q2 2018. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Creative Planning held 948 shares of Cytosorbents Corp worth $7.09K as of Q2 2026.
  • Creative Planning sold 117 Cytosorbents Corp shares in Q2 2026, an estimated $1.24K.
  • Cytosorbents Corp made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4238 holding.
  • Creative Planning first reported a position in Cytosorbents Corp in Q4 2015 and has held it in 40 quarters since.
  • Creative Planning's Cytosorbents Corp position peaked at $617K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.